Second Ebola vaccine receives approval by European Commission
The medical and pharmaceutical company Johnson & Johnson has received approval for their Ebola vaccine by the European Commission.
Both components of the two-dose vaccine for the prevention of the virus have been approved and the company hopes that this will lead to "accelerated registration" in African countries. J&J is the second company to receive approval for an Ebola vaccine after Merck.